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Abstract: The discovery of copy number variations (CNV) in the human genome opened new perspectives in the study of 
the genetic causes of inherited disorders and the etiology of common diseases. Differently patterned instances of somatic 
mosaicism in CNV regions have been shown to be present in monozygotic twins and throughout different tissues within 
an individual. A single-cell-level investigation of CNV in different human cell types led us to uncover mitotically derived 
genomic mosaicism, which is stable in different cell types of one individual. A unique study of immortalized B-
lymphoblastoid cell lines obtained with 20 year interval from the same two subjects shows that mitotic changes in CNV 
regions may happen early during embryonic development and seem to occur only once, as levels of mosaicism remained 
stable. This finding has the potential to change our concept of dynamic human genome variation. We propose that further 
genomic studies should focus on the single-cell level, to understand better the etiology and physiology of aging and dis-
eases mediated by somatic variations. 
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COPY NUMBER VARIATION (CNV) OF HUMAN 
GENOME 
  Many forms of human genome variations are known and 
described including single-nucleotide polymorphisms, small 
insertion-deletion polymorphisms, variable numbers of re-
petitive sequences and genomic structural alterations. Recent 
developments in the genome-wide targeted technologies 
used to analyze structural variations have led to the identifi-
cation of thousands of heritable copy number variations 
(CNV) occurring in both phenotypically normal and affected 
subjects [1]. These are submicroscopic CNV in DNA seg-
ments ranging from kilobases (kb) to megabases (Mb) in size 
and include deletions, insertions and duplications. However, 
they do not include those variants that arise from the inser-
tion/deletion of transposable elements alone. About 24% of 
all CNV are associated with segmental duplications suggest-
ing that non-allelic homologous recombination (NAHR) has 
been frequently involved in the genesis of these CNV [2]. 
Possibly, subsets of CNV not associated with segmental du 
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plications may be formed or maintained by non-homology-
based mutational mechanisms [3]. 
  It is known that some CNV can influence gene expres-
sion and play a role in the etiology of common diseases such 
as diabetes, cancer, and heart conditions [4, 5]. Overall, 
14.5% of genes in the OMIM morbid map overlap with CNV 
[6]. Interestingly, genes highly enriched in CNV are relevant 
to molecular-environmental interactions and influence re-
sponse to specific environmental signals such as sensory 
perception of olfactory and chemical stimuli [7-10]. In addi-
tion, genes associated with disease susceptibility were found 
in regions exhibiting CNV. As example, Gonzalez [11] has 
shown that there are significant interindividual and inter-
population differences in the copy number of a segmental 
duplication encompassing the gene encoding CCL3L1, a 
potent HIV-1-suppressive chemokine and ligand for the HIV 
coreceptor CCR5. The investigation of HIV-1-positive and -
negative individuals from groups with different geographical 
origins and ancestries (e.g. Africans or Europeans) revealed 
that a low CCL3L1 copy number was a major determinant 
for enhanced HIV susceptibility [11]. CNV have been also 
observed in other mammals such as mice [12] and chimpan-
zees [13].  
METHODS TO IDENTIFY CNV 
  Though about 6558 CNV are detailed in the Database of 
Genomic Variants (http://projects.tcag.ca/variation/) it is pod-FISH  Current Genomics, 2010, Vol. 11, No. 6    427 
supposed that a certain number of CNV remains to be identi-
fied. To date, only genome-wide technologies have been 
available to detect such CNV and only DNA extracted from 
a multitude of cells could be analyzed by those approaches 
such as SNP arrays, whole-genome tiling-path array-
comparative genomic hybridization (aCGH) platform, BAC-
based aCGH and ROMA (= representative oligonucleotide 
microarray analysis) Acgh [1, 4-6]. However the detection 
frequency of de novo CNV strongly depends on the cut off 
criteria, especially when the size of an aberration is small. In 
conclusion, the confirmation of CNV via alternative tech-
niques is particularly challenging.  
  Recently, two single-cell-directed approaches were de-
scribed as ‘parental-origin-determination fluorescence in situ 
hybridization’ (pod-FISH) [14] and ‘polymorphic deletion 
probe-based FISH’ (PDP-FISH) [15]. These techniques re-
quire CNV-region-specific bacterial artificial chromosomes 
(BAC; pod-FISH) and fosmid clones (PDP-FISH) to visual-
ize copy number polymorphisms on homologous chromo-
somes. Pod-FISH is available for 225 CNV, based on spe-
cific BAC clones of more than 150 kb in length and with 
variation frequencies in populations of over 10%. The se-
lected polymorphic regions represent size variations, detect-
able as different signal intensities with pod-FISH [14]. In 
contrast, PDP-FISH has been reported for three CNV loci 
using fosmid probes, which distinguish signal presence and 
absence rather than signal intensity differences [15]. 
SOMATIC MOSAICISM OF CNV 
  For a long time it has been widely accepted that all cells 
in an individual are genetically identical, except for indi-
viduals with somatic mosaicism that causes disease, and for 
the rearrangements of the immunoglobulin and T-cell-
receptor genes [16]. In contrast, more and more data are 
available demonstrating genomic variation in different tis-
sues for numerical chromosome aneuploidy contributing to 
mosaicism as a global mechanism for example in germ cells, 
placenta, human brain, skin, liver and blood [17-20]. How-
ever, recent studies indicate that somatic mosaicism affecting 
known CNV might be seen as a rule rather than an excep-
tion. It has been suggested that sequence variation involving 
CNV between two normal subjects is higher than that for 
single-nucleotide polymorphisms [6]. The latter suggestions 
were confirmed as so-called putative de novo somatic CNV 
events in monozygotic (MZ) twins [21]. It is expected that 
MZ twins are genetically identical and that phenotypic dif-
ferences between twins are mainly due to environmental 
factors.  
Somatic CNV Mosaicism in Monozygotic Twins 
  Bruder [21] has investigated whether MZ twins display 
differences in CNV. The study of 19 pairs of MZ twins using 
the 32K BAC array platform revealed evidence for large 
scale CNV among them and suggests that these variations 
may be common, notably in somatic development. It was 
shown that the applied array platform was able to discover 
somatic mosaicism in 10-20% of nucleated blood cells. In 
one individual of the studied MZ twins two deletions in 4p 
and 11q, encompassing ~85 and ~22Mb, respectively, were 
found. Consultation of medical records revealed that this 
subject was diagnosed with chronic lymphatic leukemia 
(CLL) prior to sampling of his blood in the course of the 
study [22]. It remains to be assessed if the CNV were causa-
tive for the CLL.  
  In addition to the concordant SNP genotypes, including 
several CNV that were shared by both twins of a pair, also a 
few discordances in A and B allele frequencies were found, 
suggesting putative de novo somatic CNV events. For in-
stance, a CNV, which covers ~1.6 Mb on chromosome 2 and 
extends from SNP rs2304429 to rs1662987, implying a dele-
tion, was found in one twin but not in the other. Two other 
methods (high-resolution melting curve analysis and pyrose-
quencing) have confirmed the deletion and indicated that it 
was present in approximately 70–80% of blood cells. The 
structural variations discovered in MZ twins suggest that 
somatic mosaicism for CNVs is relatively common in nor-
mal human cells [21].  
Somatic CNV Mosaicism within Humans 
  A recent study of different human tissues and organs 
from three subjects using a genome-wide tool (32K array) 
revealed the existence of somatic CNV mosaicism [22]. At 
least six CNV, affecting a single organ or one or more tis-
sues of the same subject were observed. Cortex of the brain, 
pons and cortex of the cerebellum were obtained from three 
individuals and RP11-197P23 located in 1p36.33 showed 
variation only in experiments using the pons vs cerebellum 
of subject 3. Thus, it was suggested that somatic mosaicism 
for CNV occur in a substantial fraction of human cells. 
Somatic CNV Mosaicism within Mice 
  It has been shown that extensive de novo and recurrent 
CNV occur also in vitro in mouse embryonic stem cell lines 
derived from common parental lines, leading to mosaic ani-
mals containing variants of the zygote genome [23]. Clones 
with major chromosomal changes could not be transmitted 
into the mouse germ line and typically exhibited trisomies or 
multiple deletions or duplications. Some clones had a few 
small (1 to 2 Mb) CNV that did not affect germ-line trans-
mission. More than half of these CNV appear to have arisen 
independently because they were observed in subclones iso-
lated from different parental ES cell lines. 
  Overall, somatic CNV mosaicism patterns have not yet 
been fully resolved, because all previous studies were per-
formed with whole-genomic DNA extracted from a large 
number of cells, approaching one million per assay. 
RECENT NEW INSIGHTS 
  As mentioned above PDP-FISH [15] and pod-FISH [14] 
provided recently the possibility to assess CNV variations in 
situ. The efficient use of both approaches in the clinical as-
sessment of chimerism in hematopoietic stem cell transplan-
tation, the exclusion of maternal contamination in prenatal 
diagnosis, the detection of uniparental disomy of single 
chromosomes, the determination of the origin of aberrant 
chromosomes, the proof of paternity by chromosomes and 
following single chromosomes in generations, was suggested 
and demonstrated [14, 15]. It is to emphasize that, in contrast 
to genome-wide approaches by pod-FISH it is possible to 428    Current Genomics, 2010, Vol. 11, No. 6  Mkrtchyan et al. 
detect small deletions or duplications with a resolution of 
150 kb and less on single cell level. Thus, this is a powerful 
approach for the discovery of adequately sized somatic mo-
saicism within a population of cells derived from one indi-
vidual.  
CNV Detection on a Single Cell Level in Clinical Cases 
  We have found not only interindividual differences, as 
expected, but also intraindividual differences determining 
the signal intensities of polymorphic BAC probes. Thus, in a 
woman with Turner syndrome and the mosaic karyotype 
45,X,der(7)t(Y;7)(p11.1~11.2;p22.3)[122]/45,X[48], pod-
FISH assessed the parental origin of the normal and deriva-
tive chromosomes 7 with two BACs (RP11-533E18 and 
RP11-45N9) of the 15 BACs tested [24]. Uniparental disomy 
7 was excluded for both cell lines and the result was con-
firmed by microsatellite analysis. The pod-FISH results for 
this individual revealed the presence of different clonal cell 
lines within one tissue with respect to the investigated CNV 
[24]. 
CNV Detection on a Single Cell Level in Leukemia 
  pod-FISH [14] and PDP-FISH [15] have also been ap-
plied to the analysis of cellular chimerism after bone-marrow 
transplantation in leukemia patients. To identify a low level 
of chimerism, it is necessary to find polymorphic regions 
containing CNV in 100% of the transplantation recipient and 
donor cells. Using pod-FISH this condition was fulfilled for 
BAC RP11-367L15, mapping to chromosome 19p13.2, in a 
male suffering from AML1–ETO-positive acute myeloid leu-
kemia (AML). After bone-marrow (BM) transplantation 
from a female donor, the cellular chimerism in BM was de-
termined in 60% donor vs 40% recipient cells using a cen-
tromeric probe for the X chromosome. Surprisingly, no sig-
nal intensity variation for RP11-367L15 was found in 55% 
of the donor cells. The remaining 45% of donor cells showed 
the identical pod-FISH signal pattern as those of the recipi-
ent cells (see Fig. 1). 
CNV Detection on a Single Cell Level in 3 Tissues of 10 
Probands  
  Intraindividual differences detectable by pod-FISH turn 
out to be a common observation rather than an exception. To 
test whether different cell types have specific CNV patterns 
when studied at the single-cell level, we used chromosome-
specific pod-FISH on metaphase spreads from 10 healthy 
individuals [16]. Three cell types were studied using 5 BACs 
with expected high population frequencies within CNV re-
gions: T lymphocytes prepared from phytohemagglutinin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Single cell estimation of a copy number variation (CNV) by pod-FISH in an AML patient 
a.  Different signal intensities for the CNV in 19p13.2 (RP11-367L15) are apparent on the two homologous chromosomes 19 in all 
metaphases of an AML patient with a t(8;21)(q22;q22.3) before bone-marrow transplantation.  
b.  Interphase nucleus of the same AML-patient exhibiting the two fusion signals (f) typical for the t(8;21)(q22;q22.3). 
c.  In the bone-marrow donor cells without the fusion signals for AML/ETO, 55% of the cells showed no signal intensity difference in 
the CNV region detected with RP11-367L15. 
d.  However, the remaining 45% of the recipient cells showed signal intensity differences identical to those of the recipient.  pod-FISH  Current Genomics, 2010, Vol. 11, No. 6    429 
(PHA)-stimulated peripheral blood; B-lymphocytes from 
Epstein–Barr-virus-immortalized B-lymphoblastoid cell 
lines (LCL) [25]; and fibroblasts from cultivated skin biopsy 
samples. In single cell types, we found cells with different 
and equal signal intensities for the same polymorphic BAC, 
varying between 0% and 95%, and random variations be-
tween all 10 individuals studied. Surprisingly, the variation 
ratio within the cells of one individual remained similar in all 
three cell types studied (P > 0.05). The results of this study 
suggest that somatic variation of CNV regions occurs in 
early embryogenesis [16]. To investigate whether once ac-
quired CNV variations ratio remain stable through the whole 
life or undergo changes, we applied pod-FISH for 36 CNV 
on metaphase spreads of LCL from two individuals (subjects 
1 and 2) established with a time interval of 20 years [16]. 
The age of the two probands was 25 and 30 years for the first 
sample, respectively. Cytogenetic analyses of all samples 
were performed using GTG banding and normal karyotypes 
were found [26, 27]. The experimental procedures performed 
on human tissue samples were approved by the Ethics 
Committee of Friedrich Schiller Jena University Hospital 
(internal code 1457-12/04). pod-FISH was done as previ-
ously reported [14]; the applied 36 BAC probes are listed in 
Fig. (2). Statistical analysis was performed using t-test 
(P=<0,01). As in previous studies also here we found two 
cell types with different signal intensity of the same BAC 
ranging from 0% to 100%. Interestingly, the variation ratio 
of BACs remained equal in LCL from different time points 
within a subject (Fig. 2) and varied between the two indi-
viduals studied [16].  
Somatic CNV Mosaicism is a Common Finding 
  The mechanisms underlying the establishment of CNV 
mosaicism and their transmission through ‘mitosis remain 
unclear. Single-cell-CNV-focused approaches might only 
uncover a tip of the iceberg in the recently reported back-
ground of extensive chromosomal instability in human 
cleavage-stage embryos [28]. Several studies have predicted 
that some CNV and nonrecurring copy number variations in 
cancer cell lines, which are induced by aphidicolin or occur 
in some cases of Duchenne muscular dystrophy, Smith-
Magenis syndrome or Pelizaeus–Merzbacher disease origi-
nate from nonhomologous end joining, fork stalling and 
template switching, or microhomology/microsatellite-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Results of pod-FISH analysis of two LCLs derived from one male subject established within a time interval of 20 years. The frac-
tion of distinguishable cell lines by pod FISH remained practically the same for all 36 investigated CNV loci within the 20 year time interval. 430    Current Genomics, 2010, Vol. 11, No. 6  Mkrtchyan et al. 
induced replication mechanisms [29, 30]. Moreover, such 
evolutionarily and developmentally significant hotspots as 
fragile sites and aphidicolin-induced CNV might resemble 
human CNV [29]. 
CONCLUSION 
  Overall, the presence of somatic CNV mosaicism in dif-
ferent individuals has been confirmed by several studies: 
Here we approach the problem of CNV mosaicism in differ-
ent cell types and tissues of the same organism in different 
cell types and tissues of the same organism at differentially 
stages. The stable variation ratios of CNV detectable by pod-
FISH have been shown to differ between individuals but not 
within healthy individuals. We suggest that the somatic re-
combination of polymorphic regions might occur at least at a 
relatively early time point in embryogenesis because all the 
well-differentiated cells studied have similar CNV mosaic 
patterns [16]. This hypothesis is substantiated by new find-
ings of complex chromosomal imbalances involving not only 
whole chromosome abnormalities and uniparental disomies 
but also segmental deletions, duplications, and amplifica-
tions in human cleavage-stage in vitro-fertilized embryos 
[28]. Interestingly, when a CNV pattern is once established, 
the variation ratio seems to be stable throughout all tissues 
and remains similar during the whole life, as the data pre-
sented here underline. 
  Understanding these phenomena in more and finer details 
should open new perspectives in developmental physiology 
and in personalized medicine. The intraindividual specific 
mosaicism ratio at a certain disease susceptibility gene might 
have a higher impact than previously expected, especially for 
so-called ‘multi-factorial diseases’, and might also explain 
clinical genetic phenomena like diminished penetrance in 
autosomal dominant diseases or clinical signs without appar-
ent mutations when only a single tissue is screened. 
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